4//SEC Filing
Reine Allan 4
Accession 0001562180-18-001252
CIK 0001583648other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:15 PM ET
Size
8.3 KB
Accession
0001562180-18-001252
Insider Transaction Report
Form 4
Reine Allan
See Remarks
Transactions
- Award
Stock Options (Right to buy)
2018-02-20+50,000→ 50,000 totalExercise: $5.00Exp: 2027-08-08→ Common Stock (50,000 underlying) - Award
Stock Options (Right to buy)
2018-02-20+53,833→ 53,833 totalExercise: $8.56Exp: 2028-02-20→ Common Stock (53,833 underlying)
Footnotes (2)
- [F1]The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
- [F2]On August 9, 2017, the reporting person was granted an option to purchase up to a maximum of 50,000 shares of common stock of which 50,000 shares were earned based on the reporting person's achievement of his 2017 personal goals as certified by the Compensation Committee of the Board of Directors on February 20, 2018. The earned shares vest as to 25% on February 20, 2019 and the remainder vests as to an additional 6.25% quarterly thereafter beginning on the last day of the next calendar quarter.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:15 PM ET
- Size
- 8.3 KB